Global Organ Preservation Solutions Market US$ 255 Million by 2021

Global Organ Preservation Solutions Market US$ 255 Million by 2021

The technology of organ preservation has improved considerably and being constantly modified to provide improved organ storage and outcomes. Several organ-preservation solutions are available and are currently used for kidney, liver, pancreas, small-bowel, lung, and heart transplantation.

According to a market research report Organ Preservation Solutions Market 2017-2021, published by iHealthcareAnalyst, Inc., the global organ preservation solutions market is estimated to reach US$ 225 Million in 2020, expanding at a CAGR of 13.0% from 2017 to 2021.

Visit the Organ Preservation Solutions Market 2017-2021 report at https://www.ihealthcareanalyst.com/report/organ-preservation-solutions-market/

The global organ preservation solutions market segmentation is based on solution (Viaspan, Custodiol HTK Solution, Renograf, Hypothermosol, Perfadex, Lifor, Human bioSystem solution, siRNA Transplant solution, etc.), and its preservation techniques (hypothermic perfusion preservation, static cold storage, etc.).

The global organ preservation solutions market report provides market size (Revenue US$ Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021). The global organ preservation solutions market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

1. Solution Type
1.1 Viaspan
1.2 Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) Solution
1.3 Renograf
1.4 Hypothermosol
1.5 Perfadex
1.6 Lifor
1.7 Human bioSystem(HSB) Solution
1.8 siRNA Transplant Solution
1.9 Others

2. Preservation Technique
2.1 Hypothermic Perfusion Preservation
2.2 Static Cold Storage
2.3 Others

3. Geography (Region, Country)
3.1 North America (U.S., Canada)
3.2 Latin America (Brazil, Mexico, Rest of LA)
3.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4 Asia Pacific (Japan, China, India, Rest of APAC)
3.5 Rest of the World

4. Company Profiles
4.1 21st Century Medicine
4.2 BioLife Solutions, Inc.
4.3 BioTime, Inc.
4.4 Bristol-Myers Squibb
4.5 Claris Lifesciences Limited
4.6 CroLife, Inc.
4.7 Dr. Franz Kohler Chemie GmbH
4.8 Lifeline Scientific
4.9 Teva Pharmaceutical Industries Ltd.
4.10 ToleroTech, Inc.
4.11 XVIVO Perfusion AB

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: [email protected]
Website: https://www.ihealthcareanalyst.com 

2017-11-05T09:53:44+00:00 Categories: Press Releases|